Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss

ConditionPresbyacusis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitut Pasteur

About this trial

Age-related hearing loss, or presbycusis, is caused by many genetic and environmental factors. Its prevalence poses a public health challenge of early identification and effective hearing aid treatment. However, the lack of screening and of a validated audiological test battery to diagnose an individual's needs and to guide hearing aid adjustments is a major obstacle.

Furthermore, monogenic forms of hearing loss affect only one functional module of hearing. The audiological test(s) dependent on the function of this module are affected, in a progressive manner, but not the others. A previous study showed that in early onset presbycusis patients, a quarter of the subjects tested were affected by monogenic presbycusis.

The collection of audiological and vestibular tests, carried out on proven monogenic presbycusis patients and compared to that of normal hearing patients, would constitute a battery of tests allowing a precision diagnosis, then developed to all forms of presbycusis in order to study if the identification of abnormal functional modules can usefully guide the diagnosis and the early fitting.

Eligibility criteria

Qualifiers

Be over the age of 18,

Be affiliated to a social security system,

Have a good command of the French language (oral and written).

Over the age of 40, having a hearing aid recipient or coming for a first hearing aid recipient

Disqualifiers

Report having been chronically exposed to loud sounds.

Have a history of ototoxic substances,

To have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing or balance,

Have an ethnic origin for which the Pasteur Institute does not have information on the frequency of variants of the genes studied.

Trial design

Treatments tested in this trial

  • Audiological and vestibular tests
  • Blood sampling
  • neurocognitive self-questionnaire

Treatment groups

700 Participants
are divided into 1 treatment group

Sponsors and collaborators

Institut Pasteur

Lead sponsor

CEntre de Recherche et d'Innovation en Audiologie Humaine

Collaborator

Laboratoire de correction auditive

Collaborator